跳至主要内容
临床试验/NCT03721380
NCT03721380已完成不适用

Efficacy of Drug and Risk Behavior Counseling Intervention Among Injecting Drug Users at Opioid Substitution Treatment

National Taiwan University0 个研究点目标入组 118 人开始时间: 2012年5月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
118
主要终点
Change in heroin use

研究概览

简要总结

Behavior drug and risk reduction counseling (BDRC), a structured, non-intense, cognitive-behavioral approach intervention designed to increase methadone maintenance treatment retention and reduce drug use and related risk behaviors among IDUs.

详细描述

Techniques of the Cognitive Behavior Therapy combined with drug dependence psychoeducation was developed by research team. BDRC consists of 12 sessions, including an initial session, 3 drug education sesssions, psychosocial counseling and behavioral skills. This initial session is designed to introduce the counselor, review the purpose and expectations of counseling, review the rules of confidentiality, agree on attendance times and rescheduling rules, and to begin to collect information from the participant on their drug use and risk behaviors. Behavioral contracting is a key component to this counseling approach. Drug education focuses on how heroin may influence patients' cognitive function and their HIV/HCV risk behaviors. Counseling and behavior skills trained patients to reflect their thoughts and learned new life skills in order to delay or abstrain from heroin use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Enrollment in opioid substitution treatment
  • Injected heroin within past 30 days by self-report, documented by "tracks" or puncture marks
  • 20 or more years of age
  • Meets ICD-10 criteria for opiates dependence with physiologic features
  • Agrees to keep bi-weekly appointments if selected
  • Current address within Taipei and Keelung, and not planning to move
  • Willingness and ability to give informed consent and otherwise participate
  • Provision of adequate locator information

排除标准

  • Clinically significant cognitive impairment, schizophrenia, paranoid disorder, bipolar disorder
  • Advanced neurological, cardiovascular, renal, or other medical disorder that is likely to impair or make hazardous patient's ability to participate
  • Physiologically dependent on alcohol, benzodiazepines or other sedative type drugs
  • Concurrent participation in another treatment study
  • Planning to enter inpatient or residential treatment within next year
  • Pending legal charges with likely incarceration within next 12 months

结局指标

主要结局

Change in heroin use

时间窗: 3, 6, and 12 months

Testing patients' urine for heroin use

次要结局

  • Number of treatment section(Within 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tony Szu-Hsien Lee

Professor

National Taiwan University

相似试验